Clinical Trial Update: A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder [Phase 2]

View source ↗

Summary

A Phase 2 study assessing centanafadine in adults with binge eating disorder reports on its efficacy, safety, and tolerability, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Centanafadine (centanafadine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Binge-Eating Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-09-09